View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0920-0978
ICR Reference No:
202312-0920-011
Status:
Historical Active
Previous ICR Reference No:
202302-0920-009
Agency/Subagency:
HHS/CDC
Agency Tracking No:
0920-0978-24BX
Title:
[NCEZID] Emerging Infections Program
Type of Information Collection:
No material or nonsubstantive change to a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved with change
Conclusion Date:
01/02/2024
Retrieve Notice of Action (NOA)
Date Received in OIRA:
12/29/2023
Terms of Clearance:
CDC should consider comments received regarding appropriate description of changes and standards for submission of nonsubstantive change requests. In line with comments, CDC should make any necessary adjustments in its next submission to OMB and discuss the use of a nonsubstantive change with the desk officer in advance of a request’s formal submission when there is uncertainty about whether it meets the standards/expectations. Previous terms continue. Approval is consistent with the understanding that CDC will continue to add (and keep current) language on each program's website and in their reports that clearly caveats the interpretation of longitudinal trends due to temporal changes in methods, definitions, geographic coverage.
Inventory as of this Action
Requested
Previously Approved
Expiration Date
02/28/2026
02/28/2026
02/28/2026
Responses
127,703
0
132,520
Time Burden (Hours)
56,133
0
53,784
Cost Burden (Dollars)
0
0
0
Abstract:
The Emerging Infections Programs (EIP) is to 1) detect and monitor emerging pathogens, the diseases they cause, and the factors influencing their emergence, and respond to problems as they are identified, 2) integrate laboratory science and epidemiology to optimize public health practice, 3) strengthen infrastructure to support surveillance and research and to implement prevention and control programs, and to 4) ensure implementation of prevention strategies and communication of public health information about emerging diseases. Surveillance efforts of the core EIP activities generate reliable estimates of the incidence of certain infections and provide the foundation for a variety of epidemiologic studies. All requested changes represent minor modifications to already-approved instruments including revised formatting, rewording, updated data set value options, and the subtraction of a limited number of questions.
Authorizing Statute(s):
US Code:
42 USC 301
Name of Law: Public Health Service Act
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
87 FR 4891
01/31/2022
30-day Notice:
Federal Register Citation:
Citation Date:
87 FR 24305
04/25/2022
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
33
IC Title
Form No.
Form Name
2024 Active Bacterial Core Surveillance (ABCs) Case Report
CDC 52.12A REV 2019
2024 Active Bacterial Core Surveillance (ABCs) Case Report
ABCs H. Influenzae Neonatal Sepsis Expanded Surveillance Form
0920-0978
ABC H. Influenzae Neonatal Sepsis Expanded Surveillance Form
ABCs Invasive Pneumococcal Disease in Children and Adults
CDC 52.15A REV.8-2023
ACTIVE BACTERIAL CORE SURVEILLANCE (ABCs) INVASIVE PNEUMOCOCCAL DISEASE IN CHILDREN (aged ≥2 months to <5 years) AND ADULTS (aged ≥65 years)
ABCs Severe GAS Infection Supplemental Form
0920-0978
ABC Severe GAS Infection Supplemental Form
Active Bacterial Core Surveillance (ABCs) Neonatal Infection Expanded Tracking Form
0920-0978
Active Bacterial Core Surveillance (ABCs) Neonatal Infection Expanded Tracking Form
Flu Surv NET Laboratory Survey
CS341327-A 7/31/2023
FluSurv-NET Laboratory Survey 2023–2024 Season
FluSurv-Net Influenza Hospitalization Surveillance Network Case Report Form
CS340190-A
2023-24 Influenza Hospitalization Surveillance Network (FluSurv-NET) Case Report Form
FluSurv-Net Influenza Hospitalization Surveillance Project Provider Vaccination History Fax Form (Children/Adults)
0920-0978-24BX
FluSurv-Net Influenza Hospitalization Surveillance Project Provider Vaccination History Fax Form (Children/Adults)
FluSurv-Net Influenza Hospitalization Surveillance Project Vaccination Phone Script and Consent Form (English/Spanish)
0920-0978-24BX
FluSurv NET Vaccination Phone Script
FoodNet Campylobacter
FoodNet Cyclospora
FoodNet Hemolytic Uremic Syndrome (HUS)
0920-0978
FoodNet CDC's FoodNet Hemolytic Uremic syndrome (HUS) Surveillance Case Report Form
FoodNet Listeria monocytogenes
FoodNet Salmonella
FoodNet Shiga toxin producing E. coli
FoodNet Shigella
FoodNet Vibrio
FoodNet Yersinia
Foodnet Clinical Laboratory Practices and Testing Volume
HAIC - CDI Case Report and Treatment Form
CS 342179-A 8/3/2023
CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) SURVEILLANCE EMERGING INFECTIONS PROGRAM CASE REPORT
HAIC Candidemia Case Report Form
Short Form 2024
CANDIDEMIA 2024 CASE REPORT FORM
HAIC Death Ascertainment Project
0920-0978
Death Ascertainment Project Variables
HAIC Invasive Methicillin-resistant Staphylococcus aureus (MRSA)
0920-0978
Invasive Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report – 2023
HAIC Invasive Staphylococcus aureus Annual Laboratory Survey
0920-0978
CDC’s Healthcare-Associated Infections Community Interface (HAIC) Staphylococcus aureus Laboratory Survey
HAIC Invasive Staphylococcus aureus Annual Surveillance Officers Survey
0920-0978
2022 HAIC Invasive Staphylococcus aureus Supplemental Surveillance Officer Survey
HAIC Invasive Staphylococcus aureus Case Report – 2024
CDC 52.15B Rev.07-2019
Invasive Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report – 2024
HAIC MuGSI CA CP-CRE Health interview
0920-0978
Community-Associated CP-CRE Interview
HAIC Multi-Site Gram-Negative Surveillance Initiative (MUGSI) Case Report Form
CS342262-A 9/20/2023
2024 Multi-site Gram-Negative Surveillance Initiative (MuGSI) Healthcare-Associated Infections Community Interface (HAIC) Case Report
HAIC Multi-Site Gram-Negative Surveillance Initiative - Extended Spectrum Beta-Lactamase Producing Enterobacteriaceae (MuGSI-ESBL)
0920-0978
2023 MuGSI Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteriaceae/Omvasove Escjerocjoa coli (MuGSI) (HAIC) Case Report
HAIC Multi-site Gram-negative Surveillance Initiative (MuGSI) Supplemental Surveillance Officer Survey
0920-0978
MuGSI SO Survey Questionnaire
HAIC- Annual Survey of Laboratory Testing Practices for C. difficile Infections
0920-0978
Annual Survey of Laboratory Testing Practices for C. difficile Infection
HAIC- CDI Annual Surveillance Officers Survey
0920-0978
Surveillance Officer’s Survey CDC’s Emerging Infections Program Clostridioides difficile Infection (CDI) Surveillance
HAIC- EIP C. difficile Surveillance Nursing Home Telephone Survey (LTCF)
0920-0978
Emerging Infections Progrom C. difficile Surveillance Nuring Home Telephone Call Survey
HAIC- Laboratory Testing Practices for Candidemia Questionnaire
2024
2024 LABORATORY TESTING PRACTICES FOR CANDIDEMIA QUESTIONNAIRE
Influenza Hospitalization Surveillance Project Vaccination Telephone Script / Consent Form (Spanish)
0920-0978
FluSurv NET Vaccination Phone Script
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
127,703
132,520
0
-4,817
0
0
Annual Time Burden (Hours)
56,133
53,784
0
2,349
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
Yes
Burden Increase Due to:
Miscellaneous Actions
Burden decreases because of Program Change due to Agency Discretion:
Yes
Burden Reduction Due to:
Changing Forms
Short Statement:
This increase in burden hours is due solely to adjusting the number of responses per respondent after including most recent Influenza season's data to calculate the median for FluSurv-NET.
Annual Cost to Federal Government:
$36,032,895
Does this IC contain surveys, censuses, or employ statistical methods?
Yes
Part B of Supporting Statement
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
Yes
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
No
Agency Contact:
Thelma Sims 4046394771
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
12/29/2023